Loading...
The Financial Express
Swasti Lankabangla Swasti Lankabangla

Health

Industry says $6 to $18 per dose is reasonable price for coronavirus vaccine

A senior pharmaceutical industry official said on Tuesday that a price range between 5 and 15 euros ($6 to $18) per dose was reasonable for COVID-19 vaccines, reports Reuters. A price between 5 and 15 euros a dose "is a...

Confident Russia offers to share legal risks of Covid vaccine

Russia is so confident in its Covid-19 vaccine that it...

Covid vaccine trial in US still on hold, AstraZeneca says

AstraZeneca Plc said on Saturday that its Covid-19 vaccine trial...

NTAC suggests PCR, antigen, antibody tests at once

The National Technical Advisory Committee (NTAC) suggested the government on...

Short of physicians, Barishal hospital’s burns unit shuts its doors; patients suffer

Ramiz Uddin Talukder rushed his wife to Sher-e-Bangla Medical College...

One in 11 Bangladeshi adults has diabetes: Study

One in 11 adults has diabetes while 8.4 million or...

WHO says safety first as over 170 nations join COVID-19 vaccine plan

The World Health Organisation said that more than 170 countries...

Vaccine trial illnesses unlikely to be linked to shot, Oxford University says

The adverse events that led to a pause in trials...

Health management disparity-2: Oxygen, ICU shortage in districts to blame

As Covid-19 pandemic raged through Bangladesh, the lack of affordable...

Ma-Telehealth Center launched

Ma-Telehealth Center, an initiative to deliver services to pregnant and...

Infectious biomedical wastes turning hazardous amid Covid pandemic

Healthcare wastes, including PPE-related ones, are posing a serious threat...

AstraZeneca resumes trials of COVID-19 vaccine

AstraZeneca has resumed British clinical trials of its COVID-19 vaccine,...

COVID vaccine: Globe Biotech ready to start clinical trial

After a two-phase of successful animal trials in the pre-clinical...

Serum Institute puts India trials of AstraZeneca's COVID-19 vaccine on hold

Serum Institute of India has put trials of AstraZeneca’s COVID-19...

WHO wants Bangladesh take urgent action on trans fat intake

Fifteen countries, including Bangladesh, account for approximately two-thirds of the...

Coronavirus: Oxford, AstraZeneca vaccine trial on hold after 'unexplained illness'

AstraZeneca Plc on Tuesday said it has paused global trials,...

Covid-19 Telehealth Center dedicated to serve patients  

The Covid-19 Telehealth Unit served 3,04,042 persons between 18th June...

Chinese researchers identify key neuron for sleep regulation

Chinese researchers have identified a specific neuron that plays a...

Bangladesh's Covid-19 form-changing fastest in world

The form of Covid-19 is changing much faster in Bangladesh...

CNBG, Sinovac find more countries to test coronavirus vaccines

China National Biotec Group (CNBG) and Sinovac Biotech Ltd said...

Public health at risk as PHO found with excessive trans-fats in capital: Study

Chinese researchers develop prediction model for rectal cancer

Results of Russia's COVID-19 vaccine produced antibody response

UNICEF to lead global procurement, supply of COVID-19 vaccines

7,000 health workers die from Covid-19 across world: AI

11.3m people come under the umbrella of ‘Dettol Handwash Challenge’

Int'l quality face masks hit the mkt

Urmi Group has launched a three-layered antiviral and antimicrobial face mask 'Turaag Protex' using Swiss Technology (HeiQ Viroblock) to bring world-class personal protection products for safety and within the reach of public affordability. The ‘Turaag Protex’ mask is made by applying Swiss technology (HeiQ Viroblock) which is 99.9 percent effective...

Steroids reduce risk of COVID-19 death, major study finds

China strengthens COVID-19 testing capacity nationwide ahead of flu season

12,543 hospitals, diagnostic centres apply for licence renewal

© 2020 - All Rights with The Financial Express